🇺🇸 Darunavir/r in United States

4 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Window: 22 April 2025 – 22 April 2026
Total reports: 4

Most-reported reactions

Metabolic Acidosis — 1 report (25%)
Renal Failure — 1 report (25%)
Sepsis Syndrome — 1 report (25%)
Supraventricular Tachycardia — 1 report (25%)

Source database →

Other Infectious Disease approved in United States

Frequently asked questions

Is Darunavir/r approved in United States?

Darunavir/r does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Darunavir/r in United States?

Juan A. Arnaiz is the originator. The local marketing authorisation holder may differ — check the official source linked above.